STORY FROM: Drugs & Medical Devices
Class Action Targeting Allergan’s Textured Breast Implants Filed in Calif.
September 3, 2019
LOS ANGELES — Women who allege they developed symptoms of a rare immune system cancer after being implanted with Allergan’s BIOCELL line of textured breast implants have filed a class action seeking compensation for surgery to remove their implants, medical monitoring, and other medical expenses.
In an August 27 complaint filed in the U.S. District Court for the Central District of California, the two plaintiffs accuse Allergan of failing to warn their doctors that the since-recalled BIOCELL implants could cause breast-implant associated anaplastic large-cell lymphoma (BIA-ALCL).
According to the complaint, McGhan Medical Corp. originally developed the BIOCELL textured implants ...
Associated Law Firms